Skip to main content

Two health-tech companies went public on Thursday, with both meeting salubrious investor demand for their shares.

Both Livongo Health (LVGO) and Health Catalyst (HCAT) jumped in their first day of trading.

Livongo, a Mountain View, Calif.-based platform enabling people with chronic conditions to better manage their health, had priced its initial public offering of 12.7 million shares at $28 on Wednesday evening.

The company gave the underwriters an option on 1.9 million more shares.

On Thursday, Livongo stock was trading at $40.04, up 43%, after trading as high as $45.46, up 62%.

Morgan Stanley, Goldman Sachs and JP Morgan are lead book-running managers for the offering.

Health Catalyst, the Salt Lake City provider of data and analytics technology and services to healthcare organizations, on Wednesday priced seven million shares at $26.

The stock was recently trading up 46% at $37.89.

Underwriters received an option on an additional 1.05 million shares.

Goldman, JP Morgan and William Blair are book-running managers.

Save 76% with our Summer Break Sale. Subscribe to our premium site Real Money and become a smarter investor! Click here today to sign up!